brighter trial underway to assess bbi-608 for advanced, metastatic gastric cancers
Published 8 years ago • 185 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
2:28
bbi608, weekly paclitaxel in advanced gastric cancer
-
8:17
metastatic gastric cancer: indications and impact of targeting the her2 pathway?
-
0:48
current and future directions in gastric cancer research
-
3:26
promising results for napabucasin plus nab-paclitaxel with gemcitabine in pancreatic cancer
-
1:55
dr. ku on combinations and sequencing of treatments for gastric cancer
-
0:49
dr. bang on pembrolizumab for advanced gastric cancer
-
1:21
phase iii trial of denosumab for breast cancer risk reduction in brca1 carriers
-
10:37
is flot the only standard in the perioperative setting for gastric cancer?
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
19:01
new agents in gastric cancer
-
22:39
gastric cancer: update on first-line therapies
-
7:02
later lines of therapy in metastatic gastric cancer
-
24:10
early detection approaches for the family of gi cancers – 2020 stanford gastric cancer summit
-
5:40
advanced/metastatic gastric cancer: beyond frontline
-
7:26
is frontline io therapy appropriate in gastric cancer?
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
9:43
new clinical trials in gastric cancer - dr. rutika mehta
-
0:35
gastrointestinal cancer trials to watch out for in 2023